{"id":135394,"date":"2026-05-14T10:00:15","date_gmt":"2026-05-14T14:00:15","guid":{"rendered":"https:\/\/www.send2press.com\/wire\/?p=135394"},"modified":"2026-05-13T19:19:39","modified_gmt":"2026-05-13T23:19:39","slug":"neurotech-reports-announces-thomas-stieglitz-ph-d-as-keynote-speaker-for-the-second-annual-neurotech-leaders-forum-imec","status":"publish","type":"post","link":"https:\/\/www.send2press.com\/wire\/neurotech-reports-announces-thomas-stieglitz-ph-d-as-keynote-speaker-for-the-second-annual-neurotech-leaders-forum-imec\/","title":{"rendered":"Neurotech Reports Announces Thomas Stieglitz, Ph.D., as Keynote Speaker for the Second Annual Neurotech Leaders Forum imec"},"content":{"rendered":"<p>SAN FRANCISCO, Calif., May 14, 2026 (SEND2PRESS NEWSWIRE) &#8212; Neurotech Reports today announced that Thomas Stieglitz, Ph.D., a globally recognized expert in neural engineering and implantable neurotechnology, will keynote the Second Annual Neurotech Leaders Forum imec, taking place June 23-24, 2026, in Leuven, Belgium.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.send2press.com\/wire\/images\/26-0514-s2p-stieglitz-800x600.jpg\" alt=\"Thomas Stieglitz, Ph.D., will keynote the Second Annual Neurotech Leaders Forum imec\" width=\"800\" height=\"600\" class=\"alignnone size-full wp-image-135373\" srcset=\"https:\/\/www.send2press.com\/wire\/images\/26-0514-s2p-stieglitz-800x600.jpg 800w, https:\/\/www.send2press.com\/wire\/images\/26-0514-s2p-stieglitz-800x600-400x300.jpg 400w, https:\/\/www.send2press.com\/wire\/images\/26-0514-s2p-stieglitz-800x600-200x150.jpg 200w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/><br \/><em>Photo caption: Thomas Stieglitz, Ph.D., will keynote the Second Annual Neurotech Leaders Forum imec.<\/em><\/p>\n<p>The Neurotech Leaders Forum brings together senior executives, investors, researchers, clinicians, and technology developers working at the forefront of neurotechnology, bioelectronic medicine, and brain-computer interface innovation. The event serves as a platform for examining emerging technologies, commercialization trends, investment activity, and the evolving direction of the neurotech industry across Europe and internationally.<\/p>\n<p>\u201cDr. Thomas Stieglitz represents the kind of visionary leadership that continues to drive the neurotechnology field forward,\u201d said James Cavuoto, editor and publisher of Neurotech Reports. \u201cHis perspective on the convergence of engineering, neuroscience, and clinical application will provide tremendous value for attendees from across the neurotech ecosystem.\u201d<\/p>\n<p>\u201cAdvances in neural interfaces and bioelectronic medicine are creating entirely new possibilities for treating neurological disorders and restoring function,\u201d said Dr. Stieglitz. \u201cI am honored to participate in this year\u2019s Neurotech Leaders Forum imec and contribute to the conversation about the future of neurotechnology.\u201d<\/p>\n<p>Dr. Stieglitz is widely recognized for his contributions to neural interface technologies and implantable systems aimed at restoring and modulating nervous system function. Throughout his career, he has combined academic leadership with entrepreneurial innovation, co-founding companies focused on neural implants and neuromodulation therapies. He has authored more than 200 scientific journal articles, contributed extensively to conference literature, and is named on dozens of patents spanning neurotechnology and biomedical engineering.<\/p>\n<p>Launched in 2025, the Neurotech Leaders Forum imec has quickly become a key meeting point for neurotechnology executives, researchers, and investors from across Europe and North America. The 2026 Forum will bring together leaders in neurostimulation, brain-computer technologies, implantable devices, AI-enabled neurotechnology, and investment at imec, one of Europe\u2019s leading research and innovation centers.<\/p>\n<p>Additional information and registration details are available at: <a href=\"https:\/\/www.neurotechreports.com\/pages\/leadersforum-europe.html\">https:\/\/www.neurotechreports.com\/pages\/leadersforum-europe.html<\/a><\/p>\n<p>More information about imec is available at: <a href=\"https:\/\/www.imec-int.com\/\">https:\/\/www.imec-int.com\/<\/a><\/p>\n<p><strong>ABOUT NEUROTECH REPORTS<\/strong><\/p>\n<p>Neurotech Reports, part of Cambridge Innovation Institute, is a leading source of market research, industry analysis, and business news covering neurotechnology, neuromodulation, and bioelectronic medicine. Through its publications and executive conferences, the company provides insights into emerging technologies, commercial trends, and investment activity shaping the global neurotech industry. Learn more: <a href=\"https:\/\/www.neurotechreports.com\/\">https:\/\/www.neurotechreports.com\/<\/a><\/p>\n<p><strong>MULTIMEDIA:<\/strong><\/p>\n<p>Photo link for media: <a href=\"https:\/\/www.Send2Press.com\/300dpi\/26-0514-s2p-stieglitz-300dpi.webp\">https:\/\/www.Send2Press.com\/300dpi\/26-0514-s2p-stieglitz-300dpi.webp<\/a><\/p>\n<p>Photo caption: Thomas Stieglitz, Ph.D., will keynote the Second Annual Neurotech Leaders Forum imec<\/p>\n<p>LOGO: <a href=\"https:\/\/www.neurotechreports.com\/images\/nlf-imecFlag-horiz.png\">https:\/\/www.neurotechreports.com\/images\/nlf-imecFlag-horiz.png<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO, Calif., May 14, 2026 (SEND2PRESS NEWSWIRE) &#8212; Neurotech Reports today announced that Thomas Stieglitz, Ph.D., a globally recognized expert in neural engineering and implantable neurotechnology, will keynote the Second Annual Neurotech Leaders Forum imec, taking place June 23-24, 2026, in Leuven, Belgium. Launched in 2025, the Neurotech Leaders Forum imec has quickly become a key meeting point for neurotechnology executives, researchers, and investors.<\/p>\n","protected":false},"author":3345,"featured_media":135373,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[603,12804,602,1,10,61,103],"tags":[869],"class_list":["post-135394","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-neurotech-news","category-ap","category-biotechnology-news","category-business-news","category-california-news","category-health-medical-news","category-san-francisco-news","tag-neurotech-leaders-forum","has-post-title","has-post-date","no-post-category","no-post-tag","no-post-comment","has-post-author"],"acf":[],"views":282,"_links":{"self":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/135394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/users\/3345"}],"replies":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/comments?post=135394"}],"version-history":[{"count":3,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/135394\/revisions"}],"predecessor-version":[{"id":135399,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/135394\/revisions\/135399"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media\/135373"}],"wp:attachment":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media?parent=135394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/categories?post=135394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/tags?post=135394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}